nodes	percent_of_prediction	percent_of_DWPC	metapath
Iopamidol—Sensation of warmth—Hydrochlorothiazide—nephrolithiasis	0.077	0.077	CcSEcCtD
Iopamidol—Leg pain—Hydrochlorothiazide—nephrolithiasis	0.0449	0.0449	CcSEcCtD
Iopamidol—Sinus bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0423	0.0423	CcSEcCtD
Iopamidol—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.0301	0.0301	CcSEcCtD
Iopamidol—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0271	0.0271	CcSEcCtD
Iopamidol—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0264	0.0264	CcSEcCtD
Iopamidol—Numbness—Hydrochlorothiazide—nephrolithiasis	0.025	0.025	CcSEcCtD
Iopamidol—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0239	0.0239	CcSEcCtD
Iopamidol—Musculoskeletal stiffness—Hydrochlorothiazide—nephrolithiasis	0.0231	0.0231	CcSEcCtD
Iopamidol—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.021	0.021	CcSEcCtD
Iopamidol—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.0201	0.0201	CcSEcCtD
Iopamidol—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0185	0.0185	CcSEcCtD
Iopamidol—Swelling—Hydrochlorothiazide—nephrolithiasis	0.0171	0.0171	CcSEcCtD
Iopamidol—Nasal congestion—Hydrochlorothiazide—nephrolithiasis	0.0165	0.0165	CcSEcCtD
Iopamidol—Injury—Hydrochlorothiazide—nephrolithiasis	0.0164	0.0164	CcSEcCtD
Iopamidol—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0161	0.0161	CcSEcCtD
Iopamidol—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.016	0.016	CcSEcCtD
Iopamidol—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0159	0.0159	CcSEcCtD
Iopamidol—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0151	0.0151	CcSEcCtD
Iopamidol—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.0145	0.0145	CcSEcCtD
Iopamidol—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0142	0.0142	CcSEcCtD
Iopamidol—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0136	0.0136	CcSEcCtD
Iopamidol—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.0133	0.0133	CcSEcCtD
Iopamidol—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0127	CcSEcCtD
Iopamidol—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0122	CcSEcCtD
Iopamidol—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0114	CcSEcCtD
Iopamidol—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0114	CcSEcCtD
Iopamidol—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0114	CcSEcCtD
Iopamidol—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0114	CcSEcCtD
Iopamidol—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.0113	0.0113	CcSEcCtD
Iopamidol—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0111	CcSEcCtD
Iopamidol—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0111	CcSEcCtD
Iopamidol—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0106	CcSEcCtD
Iopamidol—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0104	CcSEcCtD
Iopamidol—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0104	CcSEcCtD
Iopamidol—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.01	0.01	CcSEcCtD
Iopamidol—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00971	0.00971	CcSEcCtD
Iopamidol—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00967	0.00967	CcSEcCtD
Iopamidol—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0093	0.0093	CcSEcCtD
Iopamidol—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00888	0.00888	CcSEcCtD
Iopamidol—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00877	0.00877	CcSEcCtD
Iopamidol—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00872	0.00872	CcSEcCtD
Iopamidol—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00849	0.00849	CcSEcCtD
Iopamidol—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00841	0.00841	CcSEcCtD
Iopamidol—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00833	0.00833	CcSEcCtD
Iopamidol—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00818	0.00818	CcSEcCtD
Iopamidol—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00813	0.00813	CcSEcCtD
Iopamidol—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00797	0.00797	CcSEcCtD
Iopamidol—Cough—Hydrochlorothiazide—nephrolithiasis	0.00791	0.00791	CcSEcCtD
Iopamidol—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00772	0.00772	CcSEcCtD
Iopamidol—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00772	0.00772	CcSEcCtD
Iopamidol—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00769	0.00769	CcSEcCtD
Iopamidol—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00763	0.00763	CcSEcCtD
Iopamidol—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00746	0.00746	CcSEcCtD
Iopamidol—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.0074	0.0074	CcSEcCtD
Iopamidol—Shock—Hydrochlorothiazide—nephrolithiasis	0.00728	0.00728	CcSEcCtD
Iopamidol—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00722	0.00722	CcSEcCtD
Iopamidol—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00715	0.00715	CcSEcCtD
Iopamidol—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00705	0.00705	CcSEcCtD
Iopamidol—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00691	0.00691	CcSEcCtD
Iopamidol—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00674	0.00674	CcSEcCtD
Iopamidol—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00664	0.00664	CcSEcCtD
Iopamidol—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0066	0.0066	CcSEcCtD
Iopamidol—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00651	0.00651	CcSEcCtD
Iopamidol—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00643	0.00643	CcSEcCtD
Iopamidol—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00638	0.00638	CcSEcCtD
Iopamidol—Pain—Hydrochlorothiazide—nephrolithiasis	0.00633	0.00633	CcSEcCtD
Iopamidol—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.0061	0.0061	CcSEcCtD
Iopamidol—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00588	0.00588	CcSEcCtD
Iopamidol—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00585	0.00585	CcSEcCtD
Iopamidol—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00585	0.00585	CcSEcCtD
Iopamidol—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00531	0.00531	CcSEcCtD
Iopamidol—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00524	0.00524	CcSEcCtD
Iopamidol—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00506	0.00506	CcSEcCtD
Iopamidol—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00489	0.00489	CcSEcCtD
Iopamidol—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.0047	0.0047	CcSEcCtD
Iopamidol—Rash—Hydrochlorothiazide—nephrolithiasis	0.00467	0.00467	CcSEcCtD
Iopamidol—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00466	0.00466	CcSEcCtD
Iopamidol—Headache—Hydrochlorothiazide—nephrolithiasis	0.00464	0.00464	CcSEcCtD
Iopamidol—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0044	0.0044	CcSEcCtD
